紫江企業(600210.SH):擬使用暫時閒置自有資金進行委託理財的額度不超12億元
格隆匯3月21日丨紫江企業(600210.SH)公佈,為提高公司資金使用效率,合理利用自有資金,最大限度地發揮短期富餘自有資金的作用,公司本次計劃使用暫時閒置自有資金進行委託理財的額度為不超過人民幣12億元(含12億元的日動態餘額),在決議有效期內公司將在額度範圍內滾動使用。自公司第八屆董事會第十六次會議審議通過之日起12個月內有效。
董事會授權管理層及財務部門在額度範圍內負責辦理委託理財的相關事宜。公司購買理財產品的交易對方均為已公開上市的銀行及券商等金融機構,或全國性商業銀行、規模和實力較強的金融機構。交易對方與公司不存在產權、業務、資產、債權債務、人員等方面的其他關係。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.